Lucid Diagnostics Inc. · NASDAQ:LUCD
Ayrton Capital LLC's stake in Lucid Diagnostics Inc. fell to 2.00% (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 13, 2025
Ayrton Capital LLC's stake in Lucid Diagnostics Inc. fell to 2.00%, 1,200,485 shares, as a passive investor on Dec 31, 2024. Filed Feb 13, 2025 (Schedule 13G/A).
- Stake
- 2.00%
- Shares
- 1,200,485
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Ayrton Capital LLC | 2.00% | 1,200,485 |
| Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B | 2.00% | 1,200,485 |
| Waqas Khatri | 2.00% | 1,200,485 |